Rege Nephro Co., Ltd.
PrivateLast Round
Series B
Oct 7, 2024
Total Funding Raised
$28.01M
Company Overview
Rege Nephro Co., Ltd. is a biotechnology company that develops therapeutics and cell therapy for kidney, liver, and pancreas diseases using induced pluripotent stem cell (iPSC) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rege Nephro Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
Rege Nephro Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 7, 2024 | ||||
| Debt | Nov 1, 2023 | ||||
| Series A | Jan 31, 2022 | ||||
| VC Round | Jun 4, 2020 |
Key People
Founding team and executive leadership
Rege Nephro Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 株式会社日本政策金融公庫 | Debt |
| DCI Partners | Series B |
| 日本ベンチャーキャピタル株式会社 | Series B |
| Global Brain Corporation | Series B |
| DM Capital | Series A |
| Toyo Seikan Group Holdings, Ltd. | Series B |
| Chushin Venture/Investment Fund No. 5 investment limited partnership | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2025
Acquired tamibarotene-related assets from Syros Pharmaceuticals.
Rege Nephro Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rege Nephro Co., Ltd.'s valuation, stock price, and market status.
